查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594912

病人血液管理的全球市场

Patient Blood Management
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球患者血液管理市场预计将达到 236 亿美元

全球患者血液管理市场预计 2023 年为 152 亿美元，预计到 2030 年将达到 236 亿美元，2023 年至 2030 年复合年增长率为 6.4%。 「设备」是本报告分析的细分市场之一，预计复合年增长率为 6.5%，到分析期结束时将达到 101 亿美元。分析期内试剂和套件产业的复合年增长率预计为 7.1%。

美国市场估计达40亿美元，中国预计复合年增长率为9.8%

到 2023 年，美国患者血液管理市场预计将达到 40 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到56亿美元，2023年至2030年的分析期间复合年增长率为9.8%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 3.3% 和 5.8%。在欧洲，德国的复合年增长率预计为 3.7%。

全球患者血液管理市场－主要趋势与驱动因素总结

为什么患者血液管理在现代医疗保健中至关重要？

患者血液管理 (PBM) 提供了一种系统方法来优化可能需要输血的患者的护理，并已成为现代医疗保健的关键要素。 PBM 的重点是透过管理贫血、减少术中失血和优化患者的红血球量来最大程度地减少输血需求并改善临床结果。 PBM 的重要性在于它能够透过降低与输血相关的风险（例如感染疾病、免疫反应和输血相关併发症）来提高病患安全。这种以证据为基础的方法对于手术、创伤和慢性贫血的患者尤其重要，因为它减少了对血液製品的依赖并导致更快的康復。

透过最大程度地减少不必要的输血，PBM 在保存血液供应方面也发挥着重要作用，而血液供应通常有限。这种方法对于医疗保健系统至关重要，特别是在血液稀缺时期和血液製品取得机会有限的地区。由于人口老化和外科手术的增加，对血液的需求不断增加，PBM 促进了血液的有效利用，同时确保将血液输送给最需要的患者。这种做法不仅节省资源，还降低了与输血相关的医疗成本，使得 PBM 对于永续医疗管理至关重要。

此外，PBM 透过采取主动、个人化的方法来管理每位患者的血液需求，从而促进整体结果的改善。透过补充铁质、红血球生成刺激因子製剂和先进手术技术等干预措施，PBM 在手术或治疗前为患者做好充分准备。这种综合方法可以减少併发症的可能性、缩短住院时间并延长復原时间。随着医疗保健越来越强调以患者为中心的护理，PBM 提供符合现代医疗保健提供原则的客製化预防策略，提高患者满意度和健康结果。

科技进步如何增强病患血液管理？

技术进步透过引入优化血液使用、最大限度减少失血并改善患者治疗效果的新工具和方法，大大改善了患者的血液管理。 PBM 的主要创新之一是开发先进的诊断工具，能够在手术或治疗前及早发现和管理贫血。护理点 (POC) 测试和自动血液分析仪等技术可以快速评估血红蛋白和缺铁情况，使医疗保健提供者能够更早诊断和治疗贫血。准确、即时的诊断使临床医生能够主动实施个人化策略，以优化血红蛋白水平并减少需要输血的可能性。这些技术支持预防性贫血管理（PBM 的核心要素），确保患者在接受手术前处于最佳状态。

PBM 的另一个重大进展是使用细胞回收和保血手术技术，最大限度地减少术中失血并减少输血需求。术中细胞回收装置可以在手术期间收集、处理患者的血液并将其重新输入患者体内，从而减少对供血的依赖。此外，切口更小、失血更少的微创或腹腔镜手术也越来越受欢迎。这些手术对于涉及大量失血的手术特别有益，例如整形外科手术或心血管手术。透过结合细胞回收和微创技术，PBM 减少了对外部血液的需求，改善了手术结果并支持资源效率。

红血球生成刺激剂 (ESA) 和铁补充品等药物创新在 PBM 中也发挥着重要作用，它们可以促进红血球生成并在无需输血的情况下解决贫血问题。 ESA 刺激骨髓产生更多红血球，因此对于慢性贫血或接受化疗的患者特别有益。铁补充品，无论是口服还是静脉注射，都有助于优化血红蛋白，并为可能涉及出血的手术做好准备。为了促进患者健康，同时最大限度地减少输血需求，PBM 透过这些药物干预措施为贫血管理提供非输血选择。这些治疗方法使临床医生能够根据每位患者的需求量身定制 PBM 策略，并提供更有效、侵入性更小的血液管理方法。

患者血液管理如何使患者和医疗保健提供者受益？

患者血液管理为患者和医疗保健提供者提供了显着的好处，改善了患者的治疗结果，降低了医疗成本，并优化了有限血液资源的使用。对于患者而言，PBM 透过最大限度地减少感染疾病、输血反应和免疫併发症等输血相关风险来提高安全性。透过采用输血以外的干预措施，例如贫血管理、手术保存技术和使用患者自己的血液，PBM 可以降低副作用的可能性并促进更安全的医疗保健。对于接受大型手术的患者，PBM 可以保证精心管理的血液策略，优先考虑患者健康并减少输血需求，从而缩短康復时间并缩短住院时间。

对于医疗保健提供者而言，PBM 透过减少对供应量通常有限的捐血者的依赖来支持高效和永续的资源管理。由于捐血率无法跟上不断增长的需求，PBM 可以帮助为有紧急需求的患者（例如创伤或严重出血病例）保留血液资源。透过优化护理和非输血干预措施来减少血液使用，医疗保健提供者可以更有效地管理资源，降低血液短缺的风险，并确保在真正需要时提供血液製品。 PBM 也降低了与输血相关的成本，例如储存、筛检和管理成本。这种成本效率对于大型医院和卫生系统尤其有价值，因为有效管理血液资源可以节省大量资金。

改善患者治疗效果和护理品质是 PBM 的其他好处，促进更以患者为中心和个人化的医疗保健方法。透过早期发现贫血、保血外科手术、非输血选择等，PBM 使医疗保健提供者能够根据每位患者的需求制定个人化的护理计划。这种客製化方法可降低併发症的可能性，支持更快的康復，并提高患者满意度和整体护理品质。透过主动管理患者的血液健康，PBM 最大限度地减少住院和再入院次数，并创造更简化的医疗保健体验。这些好处共同改善了医疗保健服务的临床和营运方面，并支持高品质、具有成本效益、以患者为中心的护理目标。

是什么推动了患者血液管理市场的成长？

患者血液管理市场的成长是由输血相关风险意识的提高、手术和慢性病病例数量的增加、诊断和治疗技术的进步以及促进 PBM 采用的支持性监管政策推动的。人们对输血相关风险和併发症的认识不断提高，促使医疗保健提供者寻求比传统输血方法更安全、更有效的替代方法。对感染疾病、免疫反应和潜在併发症的担忧凸显了 PBM 计划的必要性，以最大限度地减少输血并提供更安全的护理选择。这种临床视角的转变导致更多的医院和医疗机构采用 PBM通讯协定，增加了对支持全面血液管理的技术和方法的需求。

手术数量的增加以及癌症、肾臟疾病和心血管疾病等慢性疾病盛行率的上升也推动了对 PBM 解决方案的需求。由于这些疾病通常需要手术干预和频繁住院治疗，因此医疗保健提供者需要有效的血液管理策略来支持患者护理，同时减少输血依赖。 PBM通讯协定在高失血量手术中特别有用，因为它们可以在手术前和手术过程中优化患者的血液状态，从而减少输血的需要。随着手术和住院数量的不断增加，对有效的 PBM 解决方案的需求也在增加，以有效管理血液和改善患者的治疗效果。

诊断和治疗技术的进步为 PBM 市场的成长做出了重大贡献，因为它们实现了更准确、更有效的个人化血液管理策略。新的诊断工具，例如现场检测和严重贫血筛检，可以对患者的血液水平进行早期疗育和精确管理。包括细胞回收装置和微创技术在内的外科创新可以减少手术过程中的失血量，并最大限度地减少对捐血的需求。红血球生成刺激因子製剂和静脉补充品等药物进步为贫血患者提供了输血以外的治疗选择。这些创新使 PBM 计划变得更加容易获得和有效，推动了世界各地医院和医疗机构的采用。

随着医疗机构和政府认识到 PBM 在提高病患安全和优化血液资源方面的价值，支持性监管政策和指南也正在推动 PBM 市场的成长。世界卫生组织 (WHO) 等监管机构和多个国家的卫生署正在鼓励医疗保健提供者采用 PBM 作为其标准治疗通讯协定的一部分。目前，许多医疗保健系统要求医院实施 PBM 策略，以符合品质标准、降低医疗成本并节省血液资源。此外，患者权益团体和医疗保健组织正在加强教育力度，以提高医疗保健专业人员和公众对 PBM 益处的认识。随着医疗保健提供者遵循最佳实践和合规标准，这些监管和宣传工作正在扩大 PBM 的采用并推动市场的显着成长。

这些因素的结合，包括对输血风险的认识、外科手术和慢性病的增加、技术进步和支持性法律规范，正在推动患者血液管理市场的强劲成长。随着医疗保健系统努力提供更安全、更具成本效益和更节约资源的护理，PBM 正在成为现代以病人为中心的护理服务的基石。

部分

产品（设备、试剂及套件、软体、配件）；组件（全血及红血球、血浆）；最终用途（血库、医院）；

调查企业举例（共42家）

  • Abbott Laboratories
  • Asahi Kasei Medical Co. Ltd.
  • B. Braun Melsungen AG
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche LTD.
  • Fresenius Se & Co. KGaA
  • Grifols, SA
  • Haemonetics Corporation
  • Immucor, Inc.
  • Kaneka Corporation
  • Livanova PLC
  • Macopharma
  • Terumo Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP22467

Global Patient Blood Management Market to Reach US$23.6 Billion by 2030

The global market for Patient Blood Management estimated at US$15.2 Billion in the year 2023, is expected to reach US$23.6 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Instruments, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$10.1 Billion by the end of the analysis period. Growth in the Reagents & Kits segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.0 Billion While China is Forecast to Grow at 9.8% CAGR

The Patient Blood Management market in the U.S. is estimated at US$4.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Patient Blood Management Market - Key Trends & Drivers Summarized

Why Is Patient Blood Management Essential in Modern Healthcare?

Patient Blood Management (PBM) has become a crucial component in modern healthcare, providing a systematic approach to optimize the care of patients who might need blood transfusions. PBM focuses on minimizing the need for blood transfusions by managing anemia, reducing blood loss during surgery, and optimizing patients' red blood cell mass, thereby improving clinical outcomes. The importance of PBM lies in its ability to enhance patient safety by reducing the risks associated with transfusions, such as infections, immune reactions, and transfusion-related complications. This evidence-based approach is especially important for patients undergoing surgeries, trauma cases, or those with chronic anemia, as it reduces dependency on blood products and leads to faster recovery.

By minimizing unnecessary transfusions, PBM also plays a significant role in conserving blood supplies, which are often in limited availability. This approach is vital for healthcare systems, particularly in times of blood shortages or in regions with limited access to blood products. With the rising demand for blood due to aging populations and increasing surgical procedures, PBM ensures that blood is available for patients who need it most while encouraging efficient blood use. This practice not only conserves resources but also lowers healthcare costs associated with blood transfusions, making PBM essential for sustainable healthcare management.

Moreover, PBM promotes better overall outcomes by taking a preventive, individualized approach to managing each patient's blood needs. Through interventions like iron supplementation, erythropoiesis-stimulating agents, and advanced surgical techniques, PBM prepares patients adequately before surgery or treatment. This comprehensive approach reduces the likelihood of complications, shortens hospital stays, and enhances recovery times. As healthcare increasingly emphasizes patient-centered care, PBM provides a tailored, preventive strategy that aligns with modern principles of healthcare delivery, improving both patient satisfaction and health outcomes.

How Are Technological Advancements Enhancing Patient Blood Management?

Technological advancements are significantly enhancing Patient Blood Management by introducing new tools and methods that optimize blood use, minimize blood loss, and improve patient outcomes. One key innovation in PBM is the development of advanced diagnostic tools that allow for early detection and management of anemia before surgery or treatment. Technologies like point-of-care (POC) testing and automated blood analyzers enable rapid hemoglobin assessments and iron deficiency evaluations, allowing healthcare providers to diagnose and treat anemia early. With accurate, real-time diagnostics, clinicians can implement personalized strategies to optimize hemoglobin levels in advance, reducing the likelihood of needing transfusions. These technologies support proactive anemia management, a core component of PBM, ensuring that patients are in the best possible condition before undergoing procedures.

Another major advancement in PBM is the use of cell salvage and blood-sparing surgical techniques, which minimize blood loss and reduce transfusion needs during surgery. Intraoperative cell salvage devices collect and process a patient’s blood during surgery, allowing it to be reinfused back into the patient, thus reducing dependency on donor blood. Additionally, minimally invasive and laparoscopic surgical techniques are becoming increasingly common, as they involve smaller incisions, leading to less blood loss. These techniques are particularly beneficial in high-blood-loss surgeries, such as orthopedic and cardiac procedures. By incorporating cell salvage and minimally invasive techniques, PBM reduces the need for external blood, improving surgical outcomes and supporting resource efficiency.

Pharmaceutical innovations, such as erythropoiesis-stimulating agents (ESAs) and iron supplements, are also playing a critical role in PBM by boosting red blood cell production and addressing anemia without the need for transfusions. ESAs stimulate the bone marrow to produce more red blood cells, which is especially beneficial for patients with chronic anemia or those undergoing chemotherapy. Iron supplements, whether oral or intravenous, support hemoglobin optimization, preparing patients for procedures that may involve blood loss. With these pharmaceutical interventions, PBM offers non-transfusion options for managing anemia, aligning with its goal to enhance patient health while minimizing transfusion requirements. These therapies empower clinicians to tailor PBM strategies to each patient’s needs, providing a more effective and less invasive approach to blood management.

What Are the Benefits of Patient Blood Management for Patients and Healthcare Providers?

Patient Blood Management provides significant benefits for both patients and healthcare providers, improving patient outcomes, reducing healthcare costs, and optimizing the use of limited blood supplies. For patients, PBM enhances safety by minimizing the risks associated with blood transfusions, such as infections, transfusion reactions, and immunologic complications. By employing non-transfusion interventions like anemia management, surgical blood-sparing techniques, and the use of patient’s own blood, PBM reduces the potential for adverse reactions and promotes a safer healthcare experience. For patients undergoing major surgeries, PBM offers the assurance of a carefully managed blood strategy that prioritizes their health, reduces the need for transfusions, and leads to quicker recovery times and shorter hospital stays.

For healthcare providers, PBM supports efficient and sustainable resource management by reducing reliance on donor blood, which is often in limited supply. With blood donation rates unable to keep pace with increasing demand, PBM helps preserve blood resources for patients with critical needs, such as trauma or severe bleeding cases. By reducing blood usage through optimized care and non-transfusion interventions, healthcare providers can manage resources more effectively, lowering the risk of blood shortages and ensuring that blood products are available when truly necessary. PBM also decreases costs associated with blood transfusions, including storage, screening, and administration expenses. This cost-efficiency is especially valuable in large hospitals and health systems, where managing blood resources effectively can lead to substantial financial savings.

Enhanced patient outcomes and quality of care are additional benefits of PBM, as it fosters a more patient-centered, individualized approach to healthcare. Through early anemia detection, blood-sparing surgical practices, and non-transfusion options, PBM enables healthcare providers to create personalized care plans tailored to each patient’s needs. This customized approach reduces the likelihood of complications and supports faster recoveries, improving patient satisfaction and overall quality of care. By proactively managing patients’ blood health, PBM minimizes hospital stays and readmissions, leading to a more streamlined healthcare experience. Together, these benefits improve both the clinical and operational aspects of healthcare delivery, supporting the goal of high-quality, cost-effective, and patient-centered care.

What Is Fueling the Growth in the Patient Blood Management Market?

The growth in the Patient Blood Management market is driven by the rising awareness of transfusion-related risks, increasing surgical and chronic disease cases, advancements in diagnostic and therapeutic technologies, and supportive regulatory policies promoting PBM adoption. As awareness grows around the risks and complications associated with blood transfusions, healthcare providers are increasingly seeking safer and more effective alternatives to traditional transfusion practices. Concerns over infections, immunologic reactions, and potential complications have highlighted the need for PBM programs that minimize transfusions and provide safer care options. This shift in clinical perspective has encouraged more hospitals and healthcare facilities to adopt PBM protocols, driving demand for technologies and practices that support comprehensive blood management.

Increasing numbers of surgeries and the rising prevalence of chronic diseases, such as cancer, kidney disease, and cardiovascular conditions, are also fueling the demand for PBM solutions. With these conditions often requiring surgical interventions or frequent hospitalizations, healthcare providers need effective blood management strategies to support patient care while reducing transfusion dependency. PBM protocols are particularly valuable in high-blood-loss surgeries, as they optimize patient blood health before and during procedures, decreasing the need for transfusions. As the volume of surgeries and hospitalizations continues to grow, so does the demand for effective PBM solutions to manage blood efficiently and improve patient outcomes.

Advancements in diagnostic and therapeutic technologies are significantly contributing to PBM market growth, as they enable more precise, effective, and personalized blood management strategies. New diagnostic tools, such as point-of-care testing and advanced anemia screening, allow for early intervention and accurate management of patient blood levels. Surgical innovations, including cell salvage devices and minimally invasive techniques, reduce blood loss during procedures, minimizing the need for donor blood. Pharmaceutical advancements, such as erythropoiesis-stimulating agents and intravenous iron supplements, provide non-transfusion treatment options for patients with anemia. These technological innovations make PBM programs more accessible and effective, supporting their adoption in hospitals and healthcare facilities worldwide.

Supportive regulatory policies and guidelines are also driving growth in the PBM market, as healthcare organizations and governments recognize the value of PBM in improving patient safety and optimizing blood resources. Regulatory bodies like the World Health Organization (WHO) and health ministries in several countries are encouraging healthcare providers to adopt PBM practices as part of their standard care protocols. Many healthcare systems now require hospitals to implement PBM strategies to comply with quality standards, reduce healthcare costs, and conserve blood resources. Additionally, patient advocacy groups and health organizations have increased educational efforts to promote awareness of PBM benefits among healthcare professionals and the public. These regulatory and advocacy efforts are expanding the adoption of PBM, driving significant growth in the market as providers align with best practices and compliance standards.

Together, these factors—awareness of transfusion risks, increasing surgical and chronic disease prevalence, technological advancements, and supportive regulatory frameworks—are driving robust growth in the Patient Blood Management market. As healthcare systems aim to provide safer, more cost-effective, and resource-efficient care, PBM is becoming a cornerstone of modern, patient-centered healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Patient Blood Management market in terms of US$ Million by the following Component; End-Use; Product, and Geographic Regions/Countries:

Segments:

Product (Instruments, Reagents & Kits, Software, Accessories); Component (Whole Blood & Red Blood Cells, Plasma); End-Use (Blood Banks, Hospitals)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Asahi Kasei Medical Co. Ltd.
  • B. Braun Melsungen AG
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche LTD.
  • Fresenius Se & Co. KGaA
  • Grifols, S.A.
  • Haemonetics Corporation
  • Immucor, Inc.
  • Kaneka Corporation
  • Livanova PLC
  • Macopharma
  • Terumo Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Patient Blood Management - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Focus on Blood Conservation Drives Demand for Patient Blood Management (PBM) Solutions
    • Rising Incidence of Chronic Diseases Expands Addressable Market for PBM
    • Advancements in Blood Transfusion Technologies Propel Market Growth
    • Growing Use of Point-of-Care Hemoglobin Testing Drives PBM Solutions
    • Patient Blood Management Crucial for Enhancing Surgical Outcomes
    • Use of AI for Blood Utilization Optimization Sets the Stage for PBM Growth
    • Increasing Demand for Bloodless Surgery Expands PBM Applications
    • Innovations in Anemia Management Propel PBM Market Expansion
    • Focus on Reducing Blood Transfusion-Related Risks Drives PBM Adoption
    • Use of PBM in Oncology Care Expands Market Opportunities
    • Growing Adoption in Emergency and Trauma Care Expands PBM Applications
    • Use of PBM in Geriatric Care Strengthens Market Opportunities
    • Strategic Investments in Automated Blood Management Solutions Propel PBM Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Patient Blood Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Whole Blood & Red Blood Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Whole Blood & Red Blood Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Whole Blood & Red Blood Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Plasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Plasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Plasma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Patient Blood Management Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • JAPAN
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • CHINA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • EUROPE
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Patient Blood Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • FRANCE
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • GERMANY
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Patient Blood Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • INDIA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Patient Blood Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Patient Blood Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • AFRICA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030

IV. COMPETITION